U.S. flag

An official website of the United States government

NM_001048174.2(MUTYH):c.1193G>T (p.Arg398Leu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Dec 22, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000219054.10

Allele description [Variation Report for NM_001048174.2(MUTYH):c.1193G>T (p.Arg398Leu)]

NM_001048174.2(MUTYH):c.1193G>T (p.Arg398Leu)

Gene:
MUTYH:mutY DNA glycosylase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_001048174.2(MUTYH):c.1193G>T (p.Arg398Leu)
HGVS:
  • NC_000001.11:g.45331466C>A
  • NG_008189.1:g.14005G>T
  • NM_001048171.2:c.1193G>T
  • NM_001048172.2:c.1196G>T
  • NM_001048173.2:c.1193G>T
  • NM_001048174.2:c.1193G>TMANE SELECT
  • NM_001128425.2:c.1277G>T
  • NM_001293190.2:c.1238G>T
  • NM_001293191.2:c.1226G>T
  • NM_001293192.2:c.917G>T
  • NM_001293195.2:c.1193G>T
  • NM_001293196.2:c.917G>T
  • NM_001350650.2:c.848G>T
  • NM_001350651.2:c.848G>T
  • NM_012222.3:c.1268G>T
  • NP_001041636.1:p.Arg412Leu
  • NP_001041636.2:p.Arg398Leu
  • NP_001041637.1:p.Arg399Leu
  • NP_001041638.1:p.Arg398Leu
  • NP_001041639.1:p.Arg398Leu
  • NP_001121897.1:p.Arg426Leu
  • NP_001121897.1:p.Arg426Leu
  • NP_001280119.1:p.Arg413Leu
  • NP_001280120.1:p.Arg409Leu
  • NP_001280121.1:p.Arg306Leu
  • NP_001280124.1:p.Arg398Leu
  • NP_001280125.1:p.Arg306Leu
  • NP_001337579.1:p.Arg283Leu
  • NP_001337580.1:p.Arg283Leu
  • NP_036354.1:p.Arg423Leu
  • LRG_220t1:c.1277G>T
  • LRG_220:g.14005G>T
  • LRG_220p1:p.Arg426Leu
  • NC_000001.10:g.45797138C>A
  • NM_001048171.1:c.1235G>T
  • NM_001128425.1:c.1277G>T
  • NR_146882.2:n.1421G>T
  • NR_146883.2:n.1270G>T
Protein change:
R283L
Links:
dbSNP: rs748700385
NCBI 1000 Genomes Browser:
rs748700385
Molecular consequence:
  • NM_001048171.2:c.1193G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048172.2:c.1196G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048173.2:c.1193G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001048174.2:c.1193G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001128425.2:c.1277G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293190.2:c.1238G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293191.2:c.1226G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293192.2:c.917G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293195.2:c.1193G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001293196.2:c.917G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350650.2:c.848G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001350651.2:c.848G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012222.3:c.1268G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_146882.2:n.1421G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_146883.2:n.1270G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000278437Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 22, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000685561Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Mar 2, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli.

Aceto G, Curia MC, Veschi S, De Lellis L, Mammarella S, Catalano T, Stuppia L, Palka G, Valanzano R, Tonelli F, Casale V, Stigliano V, Cetta F, Battista P, Mariani-Costantini R, Cama A.

Hum Mutat. 2005 Oct;26(4):394.

PubMed [citation]
PMID:
16134147

MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.

Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, Mangold E, Caspari R, Propping P, Friedl W.

Int J Cancer. 2006 Aug 15;119(4):807-14.

PubMed [citation]
PMID:
16557584
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV000278437.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.R426L variant (also known as c.1277G>T), located in coding exon 13 of the MUTYH gene, results from a G to T substitution at nucleotide position 1277. The arginine at codon 426 is replaced by leucine, an amino acid with dissimilar properties. This variant was reported in 2/60,466 breast cancer cases and in 0/53,461 controls (Dorling et al. N Engl J Med. 2021 02;384:428-439). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000685561.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This missense variant replaces arginine with leucine at codon 426 of the MUTYH protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. In a large international case-control study, this variant was reported in 2/60466 breast cancer cases and absent in 53461 controls (PMID: 33471991). This variant has been identified in 1/251262 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024